Latest Market News

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.

Insurance Australia Group (IAG) has upgraded its FY26 financial guidance following the acquisition of RACQ’s insurance business, projecting stronger premium growth and higher profits.

Brambles Limited reported robust FY25 financial results and sustainability achievements, highlighting a $1 billion free cash flow milestone and ambitious 2030 regenerative targets at its 2025 AGM.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

VRX Silica Limited has secured four binding offtake contracts for 410,000 tonnes per annum of silica sand from its Arrowsmith North project, representing nearly half of its initial production capacity and marking a significant commercial milestone.

Amaero Ltd reports a remarkable 445% increase in quarterly revenue driven by powder sales and manufacturing scale-up, alongside securing a US$22.8 million loan and exclusive supply agreements with key defense and aerospace players.

Cochlear Limited reports steady FY25 financials alongside the launch of its innovative Nucleus Nexa cochlear implant system, setting the stage for projected double-digit profit growth in FY26.

Beacon Minerals has announced a robust Laterite Ore Reserve at its Iguana Deposit, projecting strong pre-tax cash flows and a streamlined 12-month mine life. The Pre-Feasibility Study underscores the project’s economic viability amid current gold prices.

Control Bionics has successfully raised $0.6 million through a shortfall placement, reinforcing investor confidence as it accelerates commercialisation of its neurotechnology in assistive communication and emerging sports markets.

Agrimin Limited has decided to withdraw from its Mackay Potash Project after a strategic review highlighted challenging market conditions and prohibitive holding costs. The company will now focus on other mineral opportunities in Western Australia.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Red Mountain Mining reports exceptional high-grade antimony and gold results from its Armidale Project in NSW, positioning itself strongly amid growing government support for critical minerals.